# Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

> **NCT00526591** · PHASE2 · TERMINATED · sponsor: **Jorge A. Garcia, MD** · enrollment: 17 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Everolimus
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00526591
- **Lead sponsor:** Jorge A. Garcia, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2011-07
- **Final completion:** 2011-08
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2018-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00526591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00526591, "Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00526591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*